EP2229928A1 - System and devices for aseptic handling of materials - Google Patents

System and devices for aseptic handling of materials Download PDF

Info

Publication number
EP2229928A1
EP2229928A1 EP09155764A EP09155764A EP2229928A1 EP 2229928 A1 EP2229928 A1 EP 2229928A1 EP 09155764 A EP09155764 A EP 09155764A EP 09155764 A EP09155764 A EP 09155764A EP 2229928 A1 EP2229928 A1 EP 2229928A1
Authority
EP
European Patent Office
Prior art keywords
airlock
chamber
rotatable member
isolator
materials
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP09155764A
Other languages
German (de)
French (fr)
Inventor
Søren Klavstrup Mathiasen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Divisys ApS
Original Assignee
Divisys ApS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Divisys ApS filed Critical Divisys ApS
Priority to EP09155764A priority Critical patent/EP2229928A1/en
Priority to AU2010225289A priority patent/AU2010225289A1/en
Priority to EP10710996A priority patent/EP2408417A2/en
Priority to PCT/DK2010/050064 priority patent/WO2010105629A2/en
Priority to CA2754536A priority patent/CA2754536A1/en
Publication of EP2229928A1 publication Critical patent/EP2229928A1/en
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/002Compounding apparatus specially for enteral or parenteral nutritive solutions
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65BMACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B3/00Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • B65B3/003Filling medical containers such as ampoules, vials, syringes or the like

Definitions

  • This invention relates to apparatus and devices for aseptic handling and manipulation of devices used in the pharmaceutical industry and in hospitals when handling sterile substances and devices.
  • WO 2008/009288 relates to a sterilisable connector device for establishing fluid connection between a container holding a sterile diluent liquid such as isotonic sodium chloride solution, and a vial holding a pharmaceutical compound, so that the diluent liquid and the pharmaceutical compound are mixed to provide a sterile injection fluid.
  • a sterile diluent liquid such as isotonic sodium chloride solution
  • isolator technology is prescribed to minimise human interventions in processing areas resulting in a significant decrease in the risk of microbiological contamination of aseptically manufactured products from the environment.
  • Access for equipment and materials to the isolator takes place through an airlock chamber.
  • Laminar air flow is prescribed, and the content of particles in the air must be kept below specified limits.
  • Isolators for aseptic handling and manipulation of materials are typically specified to Grade A, i.e. having a laminar air flow at a velocity of 0.36 - 0.54 m/s as a guidance value and no more than 3,500 particles of size 0.5 ⁇ m per m 3 (100 particles per cu. ft.).
  • the air outside the isolator has no more than 35,000 such particles per m 3 , i.e. no more than 10 times as many particles as the upper limit for the isolator chamber.
  • the connector device of WO 2008/009288 has an engagement member with a collar having a rim for receiving the neck of a vial by a lateral movement.
  • the engagement member In order to prevent the vial from being removed and to prevent contamination of portions to be kept sterile, the engagement member must be rotated 180 degrees whereby a member with an external thread is advanced from the engagement member and brought in contact with the rubber seal, whereby lateral movement is prevented and the vial is locked in its position in the collar of the connector device.
  • Connecting the connector device of WO 2008/009288 with a vial and a diluent-liquid container can be done manually or automatically using specialised equipment such as robot technology. Many elemental processes must be performed including the above mentioned rotation of the engagement member of the connector device.
  • the vial and the diluent-liquid container each has a neck with a rubber seal to be pierced when their contents are to be mixed.
  • their rubber seals must be sterilised.
  • sterilising is done using e.g. a swab containing a sterilising liquid such as ethanol and rubbing the area to be sterilised with the swab.
  • the invention provides a system and devices that solve the above problems.
  • the isolator and airlock system of the invention can be placed in a room where the air may contain 350,000 0.5 ⁇ m particles (10,000 particles per cu. ft.), i.e. 100 times more than the upper limit for the isolator chamber. This reduces the complexity of the entire facility where an isolator system of the invention can be installed.
  • Figures 1 and 2 show the connector device 1 disclosed in WO 2008/009288 .
  • the connector device 1 has an engagement member 14 with a collar 17 and a rim 18 on the collar.
  • a vial 23 has a neck 34 that by a lateral movement has been received in the collar 17 and retained by the rim 18.
  • the connector device 1 has a tube member 4 with an external thread, and the engagement member 14 has a bore with an internal thread in engagement with the external thread of the tube member 4.
  • the tube member 4 there is a piercing member for piercing the seal 36 of the vial.
  • a piercable cap 40 covers the piercing end of the piercing member.
  • the engagement member 14 is rotated 180 degrees whereby the tube member 4 and the piercable cap 40 are advanced so that the piercable cap 40 protrudes through the central opening 27 in the metal cap 37 covering the seal 36 and is pressed slightly against the top part 41 of the seal. Reversal of this rotation is prevented by detent means on the threaded parts, and removal of the vial is hereby prevented.
  • This structure and function is disclosed in detail in WO 2008/009288 .
  • FIG. 3 shows how the rotation of the engagement member 14 is carried out in a device according to the invention.
  • An elongate member 301 is rotatable about an axis of rotation 302.
  • the elongate member 301 has two identical ends each of which has a pair of tongues 303 with a pair of opposed walls that define a radially extending and open-ended space between the tongues.
  • the engagement member 14 of a connector device can be received in the space between the tongues in a movement radially relative to the axis of rotation 302.
  • the connector device and the attached vial are engaged e.g. by a robot gripping mechanism which places the engagement member 14 as shown in the space between the pair of tongues 303.
  • the vial 23 and the remaining parts of the connector device are held and being prevented from rotation while the entire assembly of the connector device and the vial is moved as indicated by a dashed-line arrow.
  • the engagement member 14 is rotated 180 degrees relative to the vial and the remaining parts of the connector device.
  • a small “x" on the cap 37 of the vial indicates that the vial is not rotated, and a small “o” on the engagement member 14 indicates that it is rotated together with the rotatable elongate member 301.
  • the rotation is 180 degrees and by rotation of the elongate member 301 through this angle the other end is positioned to receive the engagement member of another connecting device. Rotation through other angles than 180 degrees can also be effected if so desired. If the rotation is a fraction 1/n of 360 degrees where n is an integer number, the rotatable member can advantageously have n spaces for engaging and rotating the engagement member 14 equidistantly distributed along a circle with its centre on the axis of rotation. Thereby the rotatable member will always be left in a position ready to receive an engagement member when an engagement member leaves the space after having been rotated.
  • the device preferably has a self-aligning mechanism which aligns an empty space for receiving an engagement member to be rotated.
  • Figures 5 and 6 show a known vial 23 with a seal 36.
  • a metal cap 37 with a central opening 38 covers the seal 36.
  • the metal cap 37 is bent around the neck 35 of the vial 23.
  • the top part 41 of the seal is exposed and must be sterilised before being brought into connection with a connector device 1.
  • Figure 6 illustrates how a spraying device 60 sprays a sterilising fluid such as ethanol onto the top part 41.
  • a sterilising fluid such as ethanol
  • the fluid will have a flushing effect whereby possible particles will be removed, and possible remaining bacteria will be killed.
  • both the spraying pressure and the opening angle of the spraying cone can be varied to obtain both a flushing effect and a desired distribution of the sterilising liquid.
  • the spraying device 60 does not come into contact with any part of the vial but the sterilising liquid is sprayed onto the top part of the vial whereby contamination and cross contamination is prevented.
  • the vial 23 is oriented upside down and the spraying device 60 is arranged below the vial, but any orientation can be used.
  • spraying devices that can be used is model EFD-781 from Engineered Fluid Dispensing.
  • figure 4 is shown schematically the arrangement of a system 400 according to the invention for aseptic handling of materials, and in particular for aseptically connecting a connecting device 1 as disclosed in WO 2008/009288 to a vial and a diluent-liquid container.
  • the system 400 has an isolator chamber with arrangements for aseptic handling of the materials.
  • the handling is preferably done by programmable robots.
  • Two airlock chambers each having two sliding doors allow materials to be transported into and out of the isolator chamber.
  • Such materials include primarily connector devices, vials 23 and diluent-liquid containers to be connected, but also trays and packaging materials.
  • the system includes High Efficiency Particulate Arresting, HEPA, filters P1 and p2 and motor-driven blowers for establishing a laminar air flow in the airlock chambers and in the isolator chamber.
  • HEPA High Efficiency Particulate Arresting
  • filters P1 and p2 and motor-driven blowers for establishing a laminar air flow in the airlock chambers and in the isolator chamber.
  • a pressure which is higher than the pressure outside the airlock chambers is established, e.g. 15 Pa
  • a pressure which is higher than the pressure in the airlock chambers is established, e.g. 30 Pa. This ensures that each of the airlock chambers (with all doors closed) and in the isolator chamber meet the specifications of maximum 100 particles 0.5 ⁇ m per cu. ft. corresponding to 3,500 particles 0.5 ⁇ m per m 3 .
  • HEPA filters P3 and P4 filter the return air from the airlock chambers and the isolator chamber to ensure that e.g. drugs from vials that are broken inside the airlock chambers or the isolator chamber are filtered and not re-circulated.
  • Supplemental air for compensating the loss of air through the doors etc. is fed through HEPA filters P5 and P6 where in particular drugs from vials that are broken outside the airlock chambers or the isolator chamber are filtered and are not fed into the airlock chambers or the isolator chamber.
  • a controller In the lower compartment of the system a controller is situated. The controller controls the operation of all components of the system. Since this compartment is not a "clean" area the pressure is kept below the pressure outside the system, e.g. -15 Pa. Particle filter P9 filters the air that enters the lower compartment of the system.
  • the controller controls the robots handling and manipulation of the materials (connector devices, vials and diluent-liquid containers), the operation of the sliding doors and blower motors.
  • the controller In order to maintain aseptic conditions in the isolator chamber and the airlock chambers the controller is adapted to open an airlock door to the outside only when the corresponding airlock door to the isolator chamber is closed. This allows transport of the materials between the outside and the airlock chamber. Further, the controller will open an airlock door to the isolator chamber only when the corresponding airlock door to the outside is closed and aseptic conditions have been established in the airlock chamber. This allows transport of the materials between the airlock chamber and the isolator chamber.
  • the system may have means for monitoring when aseptic conditions actually have been established in individual ones of the airlock chambers and the isolator chamber and open a door to the isolator chamber only when it has been determined based on actual observations that aseptic conditions have been established, or the system may be suitably programmed only to open a door to the isolator chamber after a predefined delay time after the corresponding airlock chamber door to the outside was closed.
  • the airlock doors are sliding doors which require less space than traditional hinged doors.

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Manipulator (AREA)

Abstract

A system for aseptic handling of materials comprising an aseptic isolator chamber with arrangements for handling of the materials; an airlock chamber with a pair of airlock doors to the outside and to the isolator chamber, respectively. A HEPA filter system establishes a laminar air flow in the airlock chamber and a higher pressure in the airlock-chamber than outside the airlock chamber. Another HEPA filter system establishes a laminar air flow in the isolator chamber and a higher pressure in the isolator chamber than in the airlock chamber. A controller is adapted to open a first airlock door to the outside only when the second airlock door to the isolator chamber is closed, to allow transport of the materials between the outside and the airlock chamber, and to open the second airlock door to the isolator chamber only when the first airlock door is closed and aseptic conditions have been established in the airlock chamber, to allow transport of the materials between the airlock chamber and the isolator chamber.

Description

    FIELD OF THE INVENTION
  • This invention relates to apparatus and devices for aseptic handling and manipulation of devices used in the pharmaceutical industry and in hospitals when handling sterile substances and devices.
  • BACKGROUND OF THE INVENTION
  • WO 2008/009288 relates to a sterilisable connector device for establishing fluid connection between a container holding a sterile diluent liquid such as isotonic sodium chloride solution, and a vial holding a pharmaceutical compound, so that the diluent liquid and the pharmaceutical compound are mixed to provide a sterile injection fluid.
  • The handling of such connector device for establishing interconnection liquid container and vial must take place under aseptic conditions. Reference is made to e.g. the publication Manufacture of Sterile Medicinal Products, an EC Guide to manufacturing Practice by the European Commission, 30 May 2003.
  • The use of isolator technology is prescribed to minimise human interventions in processing areas resulting in a significant decrease in the risk of microbiological contamination of aseptically manufactured products from the environment. Access for equipment and materials to the isolator takes place through an airlock chamber. Laminar air flow is prescribed, and the content of particles in the air must be kept below specified limits. Isolators for aseptic handling and manipulation of materials are typically specified to Grade A, i.e. having a laminar air flow at a velocity of 0.36 - 0.54 m/s as a guidance value and no more than 3,500 particles of size 0.5 µm per m3 (100 particles per cu. ft.). This requires that the air outside the isolator has no more than 35,000 such particles per m3, i.e. no more than 10 times as many particles as the upper limit for the isolator chamber. In order to achieve this there is usually at least one further, outer airlock system.
  • The connector device of WO 2008/009288 has an engagement member with a collar having a rim for receiving the neck of a vial by a lateral movement. In order to prevent the vial from being removed and to prevent contamination of portions to be kept sterile, the engagement member must be rotated 180 degrees whereby a member with an external thread is advanced from the engagement member and brought in contact with the rubber seal, whereby lateral movement is prevented and the vial is locked in its position in the collar of the connector device. For further details reference is made to WO 2008/009288 .
  • Connecting the connector device of WO 2008/009288 with a vial and a diluent-liquid container can be done manually or automatically using specialised equipment such as robot technology. Many elemental processes must be performed including the above mentioned rotation of the engagement member of the connector device.
  • The vial and the diluent-liquid container each has a neck with a rubber seal to be pierced when their contents are to be mixed. Before connecting the vial and the diluent-liquid container to the connector their rubber seals must be sterilised. Today, such sterilising is done using e.g. a swab containing a sterilising liquid such as ethanol and rubbing the area to be sterilised with the swab. There is a potential risk of contamination and cross contamination transferred by the swab, and therefore there is a need for a method reducing this risk.
  • The invention provides a system and devices that solve the above problems. In particular, the isolator and airlock system of the invention can be placed in a room where the air may contain 350,000 0.5 µm particles (10,000 particles per cu. ft.), i.e. 100 times more than the upper limit for the isolator chamber. This reduces the complexity of the entire facility where an isolator system of the invention can be installed.
  • BRIEF DESCRIPTION OF THE DRAWINGS
    • Figure 1 shows a vial connected to a connector device;
    • Figure 2 shows the vial and the connector device in figure 1 in a configuration where the vial is locked to the connector device;
    • Figure 3 shows a system for manipulating the vial and the connector device in figure 1;
    • Figure 4 shows schematically a system according to the invention for aseptic handling of materials;
    • Figure 5 shows a vial; and
    • Figure 6 shows schematically the sterilisation of the seal of the vial in figure 5 before being connected to a connector device.
    DETAILED DESCRIPTION OF THE INVENTION
  • Figures 1 and 2 show the connector device 1 disclosed in WO 2008/009288 . The connector device 1 has an engagement member 14 with a collar 17 and a rim 18 on the collar. A vial 23 has a neck 34 that by a lateral movement has been received in the collar 17 and retained by the rim 18. The connector device 1 has a tube member 4 with an external thread, and the engagement member 14 has a bore with an internal thread in engagement with the external thread of the tube member 4. The tube member 4 there is a piercing member for piercing the seal 36 of the vial. A piercable cap 40 covers the piercing end of the piercing member.
  • In figure 1 the end of the piercable cap 40 is flush with the bottom of the cavity defined by the collar 17 which allows the top of the vial to be inserted laterally into the cavity and gripped by the rim 18 of the collar 17.
  • In order to prevent the vial 23 from being removed from the collar 17 of the engagement member 14, the engagement member 14 is rotated 180 degrees whereby the tube member 4 and the piercable cap 40 are advanced so that the piercable cap 40 protrudes through the central opening 27 in the metal cap 37 covering the seal 36 and is pressed slightly against the top part 41 of the seal. Reversal of this rotation is prevented by detent means on the threaded parts, and removal of the vial is hereby prevented. This structure and function is disclosed in detail in WO 2008/009288 .
  • Figure 3 shows how the rotation of the engagement member 14 is carried out in a device according to the invention. An elongate member 301 is rotatable about an axis of rotation 302. The elongate member 301 has two identical ends each of which has a pair of tongues 303 with a pair of opposed walls that define a radially extending and open-ended space between the tongues. The engagement member 14 of a connector device can be received in the space between the tongues in a movement radially relative to the axis of rotation 302. In the system of the invention to be described below the connector device and the attached vial are engaged e.g. by a robot gripping mechanism which places the engagement member 14 as shown in the space between the pair of tongues 303. The vial 23 and the remaining parts of the connector device are held and being prevented from rotation while the entire assembly of the connector device and the vial is moved as indicated by a dashed-line arrow. Hereby the engagement member 14 is rotated 180 degrees relative to the vial and the remaining parts of the connector device. A small "x" on the cap 37 of the vial indicates that the vial is not rotated, and a small "o" on the engagement member 14 indicates that it is rotated together with the rotatable elongate member 301.
  • In this embodiment the rotation is 180 degrees and by rotation of the elongate member 301 through this angle the other end is positioned to receive the engagement member of another connecting device. Rotation through other angles than 180 degrees can also be effected if so desired. If the rotation is a fraction 1/n of 360 degrees where n is an integer number, the rotatable member can advantageously have n spaces for engaging and rotating the engagement member 14 equidistantly distributed along a circle with its centre on the axis of rotation. Thereby the rotatable member will always be left in a position ready to receive an engagement member when an engagement member leaves the space after having been rotated. The device preferably has a self-aligning mechanism which aligns an empty space for receiving an engagement member to be rotated.
  • Figures 5 and 6 show a known vial 23 with a seal 36. A metal cap 37 with a central opening 38 covers the seal 36. The metal cap 37 is bent around the neck 35 of the vial 23. The top part 41 of the seal is exposed and must be sterilised before being brought into connection with a connector device 1.
  • Figure 6 illustrates how a spraying device 60 sprays a sterilising fluid such as ethanol onto the top part 41. By spraying the sterilising fluid the fluid will have a flushing effect whereby possible particles will be removed, and possible remaining bacteria will be killed. During spraying both the spraying pressure and the opening angle of the spraying cone can be varied to obtain both a flushing effect and a desired distribution of the sterilising liquid. The spraying device 60 does not come into contact with any part of the vial but the sterilising liquid is sprayed onto the top part of the vial whereby contamination and cross contamination is prevented.
  • In figure 6 the vial 23 is oriented upside down and the spraying device 60 is arranged below the vial, but any orientation can be used.
  • An example of spraying devices that can be used is model EFD-781 from Engineered Fluid Dispensing.
  • In figure 4 is shown schematically the arrangement of a system 400 according to the invention for aseptic handling of materials, and in particular for aseptically connecting a connecting device 1 as disclosed in WO 2008/009288 to a vial and a diluent-liquid container.
  • The system 400 has an isolator chamber with arrangements for aseptic handling of the materials. The handling is preferably done by programmable robots. Two airlock chambers each having two sliding doors allow materials to be transported into and out of the isolator chamber. Such materials include primarily connector devices, vials 23 and diluent-liquid containers to be connected, but also trays and packaging materials.
  • The system includes High Efficiency Particulate Arresting, HEPA, filters P1 and p2 and motor-driven blowers for establishing a laminar air flow in the airlock chambers and in the isolator chamber. In the airlock chambers a pressure which is higher than the pressure outside the airlock chambers is established, e.g. 15 Pa, and in the isolator chamber a pressure which is higher than the pressure in the airlock chambers is established, e.g. 30 Pa. This ensures that each of the airlock chambers (with all doors closed) and in the isolator chamber meet the specifications of maximum 100 particles 0.5 µm per cu. ft. corresponding to 3,500 particles 0.5 µm per m3.
  • HEPA filters P3 and P4 filter the return air from the airlock chambers and the isolator chamber to ensure that e.g. drugs from vials that are broken inside the airlock chambers or the isolator chamber are filtered and not re-circulated.
  • Supplemental air for compensating the loss of air through the doors etc. is fed through HEPA filters P5 and P6 where in particular drugs from vials that are broken outside the airlock chambers or the isolator chamber are filtered and are not fed into the airlock chambers or the isolator chamber.
  • In the lower compartment of the system a controller is situated. The controller controls the operation of all components of the system. Since this compartment is not a "clean" area the pressure is kept below the pressure outside the system, e.g. -15 Pa. Particle filter P9 filters the air that enters the lower compartment of the system.
  • In the isolator chamber two sterilisation stations 60 are arranged. Sterilising fluid is removed through particle filter P7 and led out through an explosion proof exhauster EX together with air from the lower compartment.
  • The controller controls the robots handling and manipulation of the materials (connector devices, vials and diluent-liquid containers), the operation of the sliding doors and blower motors. In order to maintain aseptic conditions in the isolator chamber and the airlock chambers the controller is adapted to open an airlock door to the outside only when the corresponding airlock door to the isolator chamber is closed. This allows transport of the materials between the outside and the airlock chamber. Further, the controller will open an airlock door to the isolator chamber only when the corresponding airlock door to the outside is closed and aseptic conditions have been established in the airlock chamber. This allows transport of the materials between the airlock chamber and the isolator chamber.
  • The system may have means for monitoring when aseptic conditions actually have been established in individual ones of the airlock chambers and the isolator chamber and open a door to the isolator chamber only when it has been determined based on actual observations that aseptic conditions have been established, or the system may be suitably programmed only to open a door to the isolator chamber after a predefined delay time after the corresponding airlock chamber door to the outside was closed.
  • The airlock doors are sliding doors which require less space than traditional hinged doors.

Claims (10)

  1. A system for rotating a first part a predetermined angle relative to a second part rotatably coupled to the first part, the device comprising
    - a member rotatable at least through the predetermined angle about an axis of rotation, the rotatable member having means for engaging and rotating the first part together with the rotatable member and for disengaging the first part after having been rotated through the predetermined angle, and
    - a device for engaging the second part when the first part is received by the rotatable member and for holding the second part non-rotating during the rotation.
  2. A system according to claim 1 wherein the device for engaging the second part comprises a robot-controlled device.
  3. A rotatable member for use in a system according to claim 1, the rotatable member being rotatable at least through a predetermined angle about an axis of rotation, the rotatable member having means for engaging and rotating the first part together with the rotatable member and for disengaging the first part after having been rotated through the predetermined angle.
  4. A rotatable member according to claim 3 wherein the means for engaging and rotating the first part comprises a pair of opposed walls defining a radially extending and open-ended space therebetween for receiving the first part by a movement of the first part in a radial direction relative to the axis of rotation.
  5. A rotatable member according to claim 4 wherein the predetermined angle is a fraction 1/n of 360 degrees, n being an integer and the rotatable member has n means for engaging and rotating the first part equidistantly distributed along a circle having its centre on the axis of rotation.
  6. A device for applying a sterilising fluid to a surface to be sterilised, the device comprising a spraying device for spraying the sterilising fluid onto the surface to be sterilised.
  7. A system for aseptic handling of materials, the system comprising
    - an isolator chamber with arrangements for aseptic handling of the materials;
    - an airlock chamber having a first airlock door between the airlock chamber and the outside, and a second airlock door between the airlock chamber and the isolator chamber, the first and second airlock doors allowing transport of the materials between the isolator chamber and the environment of the system;
    - a system including a High Efficiency Particulate Arresting filter for establishing a laminar air flow in the airlock chamber and an airlock-chamber pressure higher than the pressure outside the airlock chamber;
    - a system including a High Efficiency Particulate Arresting filter for establishing a laminar air flow in the isolator chamber and an isolator-chamber pressure higher than the airlock-chamber pressure;
    - a controller adapted to open the first airlock door only when the second airlock door is closed to allow transport of the materials between the outside and the airlock chamber, and to open the second airlock door only when the first airlock door is closed and aseptic conditions have been established in the airlock chamber to allow transport of the materials between the airlock chamber and the isolator chamber.
  8. A system according to claim 7 wherein the airlock doors are sliding doors.
  9. A system according to any one of claims 7-8 wherein the materials include vials and diluent-liquid containers and a connector device for establishing fluid connection between a vial and a diluent-liquid container, the system further comprising a system according to any one of claims 1-2 and a rotatable member according to any one of claims 3-5.
  10. A system according to claim 9 further comprising a device according to claim 6 for sterilising parts to be connected.
EP09155764A 2009-03-20 2009-03-20 System and devices for aseptic handling of materials Withdrawn EP2229928A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP09155764A EP2229928A1 (en) 2009-03-20 2009-03-20 System and devices for aseptic handling of materials
AU2010225289A AU2010225289A1 (en) 2009-03-20 2010-03-19 System and devices for aseptic handling of materials
EP10710996A EP2408417A2 (en) 2009-03-20 2010-03-19 System and devices for aseptic handling of materials
PCT/DK2010/050064 WO2010105629A2 (en) 2009-03-20 2010-03-19 System and devices for aseptic handling of materials
CA2754536A CA2754536A1 (en) 2009-03-20 2010-03-19 System and devices for aseptic handling of materials

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09155764A EP2229928A1 (en) 2009-03-20 2009-03-20 System and devices for aseptic handling of materials

Publications (1)

Publication Number Publication Date
EP2229928A1 true EP2229928A1 (en) 2010-09-22

Family

ID=40942381

Family Applications (2)

Application Number Title Priority Date Filing Date
EP09155764A Withdrawn EP2229928A1 (en) 2009-03-20 2009-03-20 System and devices for aseptic handling of materials
EP10710996A Withdrawn EP2408417A2 (en) 2009-03-20 2010-03-19 System and devices for aseptic handling of materials

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP10710996A Withdrawn EP2408417A2 (en) 2009-03-20 2010-03-19 System and devices for aseptic handling of materials

Country Status (4)

Country Link
EP (2) EP2229928A1 (en)
AU (1) AU2010225289A1 (en)
CA (1) CA2754536A1 (en)
WO (1) WO2010105629A2 (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998012112A1 (en) * 1996-09-18 1998-03-26 A.W.A.X. Progettazione E Ricerca S.R.L. Process and equipment for the packaging of products in a modified and controlled atmosphere
US20060003685A1 (en) * 2004-05-27 2006-01-05 Juergen Rothbauer Sterile filling arrangement
US20060259195A1 (en) * 2004-12-22 2006-11-16 Eliuk Walter W Automated pharmacy admixture system (APAS)
US7146781B1 (en) * 2004-12-06 2006-12-12 Nathan Albert Cole Apparatus and method for insertion of material into uncontaminated containers
EP1834878A1 (en) * 2006-03-15 2007-09-19 Pietro Dovesi Method for packaging of phials in a sterile environment, and apparatus for carrying out the aforesaid method
WO2008009288A1 (en) 2006-07-21 2008-01-24 Polimoon Medical Packaging A/S Connector device and method for sterile mixing
US20080169043A1 (en) * 2006-10-20 2008-07-17 Forhealth Technologies, Inc. Automated drug preparation apparatus including drug vial handling, venting, cannula positioning functionality

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998012112A1 (en) * 1996-09-18 1998-03-26 A.W.A.X. Progettazione E Ricerca S.R.L. Process and equipment for the packaging of products in a modified and controlled atmosphere
US20060003685A1 (en) * 2004-05-27 2006-01-05 Juergen Rothbauer Sterile filling arrangement
US7146781B1 (en) * 2004-12-06 2006-12-12 Nathan Albert Cole Apparatus and method for insertion of material into uncontaminated containers
US20060259195A1 (en) * 2004-12-22 2006-11-16 Eliuk Walter W Automated pharmacy admixture system (APAS)
EP1834878A1 (en) * 2006-03-15 2007-09-19 Pietro Dovesi Method for packaging of phials in a sterile environment, and apparatus for carrying out the aforesaid method
WO2008009288A1 (en) 2006-07-21 2008-01-24 Polimoon Medical Packaging A/S Connector device and method for sterile mixing
US20080169043A1 (en) * 2006-10-20 2008-07-17 Forhealth Technologies, Inc. Automated drug preparation apparatus including drug vial handling, venting, cannula positioning functionality

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MANUFACTURE OF STERILE MEDICINAL PRODUCTS, AN EC GUIDE TO MANUFACTURING, 30 May 2003 (2003-05-30)

Also Published As

Publication number Publication date
WO2010105629A3 (en) 2010-11-11
AU2010225289A1 (en) 2011-09-22
AU2010225289A2 (en) 2011-10-13
CA2754536A1 (en) 2010-09-23
WO2010105629A2 (en) 2010-09-23
EP2408417A2 (en) 2012-01-25

Similar Documents

Publication Publication Date Title
KR102054387B1 (en) Apparatus and method for aseptic filling of medical containers with medical fluid
US11866215B2 (en) Opening assembly for a package
EP4119309A1 (en) System and method for dispensing a liquid into a closed enclosure
US20050223677A1 (en) Apparatus for molding and assembling containers with stoppers and filling same
US20040241041A1 (en) Apparatus and method for fabricating a reconstitution assembly
US20050217211A1 (en) Method for molding and assembling containers with stoppers and filling same
US8181431B2 (en) Sterile de-molding apparatus and method
US20100276030A1 (en) Adjustable Needle Filling and Laser Sealing Apparatus and Method
EP2928777B1 (en) System and method for dispensing biopharmaceutical materials
CN107533781A (en) For preparing the machine and method of intravenous drug
US20240359837A1 (en) High-Speed Container Filling with Reduced Cross-Contamination
CN106061513B (en) Apparatus and method for transferring sterile product between two containers
EP2229928A1 (en) System and devices for aseptic handling of materials
CN203094481U (en) Devices for filling and closing small containers of different types of medicines
CN208454480U (en) A kind of high-end pharmacy is made up a prescription package detection transhipment intelligent robot
EP4603110A2 (en) Functional element, beta-container, transfer system and barrier system
CN116867567A (en) Devices for moving containers, equipment and methods for the production of pharmaceutical or biotechnological products
CN215944943U (en) Rubber plug subpackaging isolator
WO2025157917A1 (en) Method for dispensing, in particular aseptically dispensing, a medium, in particular a medicament
WO2024115101A1 (en) Functional element, beta container system, transfer system and barrier system
WO2025157920A1 (en) Transfer-port arrangement for transferring components into and/or out of a pharmaceutical isolator
CN120500439A (en) System for handling containers of medicine and method for operating such a system
WO2024217944A1 (en) Dosing apparatus for pharmaceutical purposes and method for operating a dosing apparatus
Izumi et al. The impact of automation on aseptic processing
Akers et al. Highly automated isolator-based vaccine filling—a case study

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA RS

17P Request for examination filed

Effective date: 20110321

AKX Designation fees paid

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

17Q First examination report despatched

Effective date: 20110829

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20140509